Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Julphar
Federal Trade Commission
AstraZeneca
Chubb
Fish and Richardson
Medtronic
Healthtrust
Daiichi Sankyo
Covington

Generated: February 25, 2018

DrugPatentWatch Database Preview

Fomivirsen sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for fomivirsen sodium and what is the scope of fomivirsen sodium freedom to operate?

Fomivirsen sodium
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for fomivirsen sodium

US Patents and Regulatory Information for fomivirsen sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis VITRAVENE PRESERVATIVE FREE fomivirsen sodium INJECTABLE;INJECTION 020961-001 Aug 26, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for fomivirsen sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis VITRAVENE PRESERVATIVE FREE fomivirsen sodium INJECTABLE;INJECTION 020961-001 Aug 26, 1998 ➤ Sign Up ➤ Sign Up
Novartis VITRAVENE PRESERVATIVE FREE fomivirsen sodium INJECTABLE;INJECTION 020961-001 Aug 26, 1998 ➤ Sign Up ➤ Sign Up
Novartis VITRAVENE PRESERVATIVE FREE fomivirsen sodium INJECTABLE;INJECTION 020961-001 Aug 26, 1998 ➤ Sign Up ➤ Sign Up
Novartis VITRAVENE PRESERVATIVE FREE fomivirsen sodium INJECTABLE;INJECTION 020961-001 Aug 26, 1998 ➤ Sign Up ➤ Sign Up
Novartis VITRAVENE PRESERVATIVE FREE fomivirsen sodium INJECTABLE;INJECTION 020961-001 Aug 26, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Citi
Chubb
Express Scripts
Accenture
Queensland Health
Fuji
Teva
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot